Title:
TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY STATIN
Document Type and Number:
WIPO Patent Application WO/2008/001752
Kind Code:
A1
Abstract:
Disclosed is a pharmaceutical composition for treatment or prevention of chronic obstructive pulmonary diseases. The pharmaceutical composition contains an HMG-CoA reductase inhibitor as an active ingredient.
Inventors:
NAGAYA NORITOSHI (JP)
Application Number:
PCT/JP2007/062768
Publication Date:
January 03, 2008
Filing Date:
June 26, 2007
Export Citation:
Assignee:
DAIICHI SANKYO CO LTD (JP)
JAPAN PRESIDENT NAT CARDIOVASCULAR CT (JP)
NAGAYA NORITOSHI (JP)
JAPAN PRESIDENT NAT CARDIOVASCULAR CT (JP)
NAGAYA NORITOSHI (JP)
International Classes:
A61K45/00; A61K31/22; A61K31/366; A61K31/40; A61K31/404; A61K31/4418; A61K31/47; A61K31/505; A61P11/00; A61P43/00; C07D207/34; C07D209/24; C07D213/55; C07D215/14; C07D239/42; C07D309/30
Domestic Patent References:
| WO2006008437A1 | 2006-01-26 |
Foreign References:
| KR20060004834A | 2006-01-16 |
Other References:
MORIMOTO K. ET AL.: "Lovastatin Enhances Clearance of Apoptotis Cells (Efferocytosis) with Implications for Chronic Obstructive Pulmonary Disease", JOURNAL OF IMMUNOLOGY, vol. 176, no. 12, 15 June 2006 (2006-06-15), pages 7657 - 7665, XP003020325
Attorney, Agent or Firm:
MAYAMA, Setsuko et al. (30-1 Tsuruyacho 3-chome, Kanagawa-ku, Yokohama-sh, Kanagawa 35, JP)
Download PDF: